Entrada crashes as Duchenne therapy comes in ‘below expectations’ in early study
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Entrada has experienced a decline after its Duchenne therapy showed results that were below expectations in an early study. The therapy's performance was not as strong as anticipated, leading to a negative impact on Entrada. The early study results have yielded disappointing outcomes for the therapy.